دانلود کتاب نانوحامل‌ها در اختلالات نورودژنراتیو: امیدها و ادعاهای درمانی Nanocarriers in Neurodegenerative Disorders: Therapeutic Hopes and Hypes 1st Edition

Due to the lack of secure, efficient, and patient-friendly therapies for neurodegenerative disorders, there is a rising demand for innovative approaches. Despite the limited number of nanocarriers approved for human use, they have demonstrated significant potential in preclinical and, in some instances, clinical trials. In alignment with this objective, the chapters of the book are structured to offer a comprehensive overview of recent advancements in medication and dosage form development, specifically emphasizing the nanoparticulate system for targeting the brain.
Contents
۱ Fundamentals of Blood–Brain Barrier Anatomy and Global Functions
۲ Blood–Brain Barrier in Neurodegenerative Disorders
۳ Neurodegenerative Disorders: Available Therapies and Their Limitations
۴ Challenges in Brain Targeting and Mechanisms of Drug Transfer across the BBB
۵ Introduction to Nanomedicine, Nanotechnology, and Nanopharmaceuticals
۶ Regulations and Ethics of Nanomedicine and Public Acceptance
۷ Safety of Nanoparticles in Medicine
۸ Enhancing Brain Drug Delivery with Lipid Nanocarriers for Bioactive Compounds
۹ Blood–Brain Barrier Disruption and Nanomedicine in Neurodegenerative Disorders
۱۰ Worldwide Development and Commercialization of Nanomedicine
۱۱ Introduction to Nanoparticles as Potential Carriers for Brain Targeting in Neurodegenerative Disorders
۱۲ Application of Polymeric Nanoparticles in Brain Targeting
۱۳ Lipid-Based Nanocarriers for Brain Delivery of Bioactives in the Treatment of Neurodegenerative Disorders
۱۴ Autophagy and Extracellular Nanovesicles: Communication and Their Therapeutic Application in Neurodegenerative Diseases
۱۵ Mesoporous Silica Nanoparticles as Promising Carriers for Brain Delivery
۱۶ Potential of Dendrimers as Nanocarriers for Brain Drug Delivery
۱۷ Surface-Active Ligands for Brain Targeting
۱۸ Nanocarriers for Brain Delivery: Safety, Stability Concerns, and Regulatory Aspects
۱۹ Advancements of Nanocarriers for Brain Targeting and Limitations in Clinical Translation
۲۰ Toward Applicability of Exosomal-ncRNA Precision vs. Nanoparticles to the Brain
۲۲ Toward Nano-Drug Precision for Neurodegenerative Diseases or Glioma